Estriol, conjugated equine estrogens, and alendronate therapy for osteoporosis.
Terauchi
M
M
Department of Comprehensive Reproductive Medicine, Graduate School, Tokyo Medical and Dental University, Bunkyo, Japan. m.terauchi.gyne@tmd.ac.jp
Obayashi
S
S
Aso
T
T
D000328:Adult; D000368:Aged; D019386:Alendronate / Q000008:administration & dosage / Q000627:therapeutic use*; D050071:Bone Density Conservation Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D004964:Estriol / Q000008:administration & dosage / Q000627:therapeutic use*; D004967:Estrogens / Q000008:administration & dosage / Q000627:therapeutic use*; D004966:Estrogens, Conjugated (USP) / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008875:Middle Aged; D015663:Osteoporosis, Postmenopausal / Q000188:drug therapy*; D012189:Retrospective Studies; D016896:Treatment Outcome
D050071:Bone Density Conservation Agents; D004967:Estrogens; D004966:Estrogens, Conjugated (USP); D004964:Estriol; D019386:Alendronate